Publications

1. Nakai H, Suman G, Adamo DA, Navin PJ, Bookwalter CA, LeGout JD, Chen FK, Wellnitz CV, Silva AC, Thomas JV, Kawashima A, Fan JW, Froemming AT, Lomas DJ, Humphreys MR, Dora C, Korfiatis P, Takahashi N. Natural language processing pipeline to extract prostate cancer-related information from clinical notes. Eur Radiol. 2024 Dec; 34 (12):7878-7891 Epub 2024 June 06
   View PubMed
2. Dane B, Froemming A, Schwartz FR, Toshav A, Ramirez-Giraldo JC, Ananthakrishnan L. Photon counting CT clinical adoption, integration, and workflow. Abdom Radiol (NY). 2024 Dec; 49 (12):4600-4609 Epub 2024 July 25
   View PubMed
3. Nakai H, Takahashi H, LeGout JD, Kawashima A, Froemming AT, Lomas DJ, Humphreys MR, Dora C, Takahashi N. Estimated diagnostic performance of prostate MRI performed with clinical suspicion of prostate cancer. Insights Imaging. 2024 Nov 15; 15 (1):271
   View PubMed
4. Kuanar S, Cai J, Nakai H, Nagayama H, Takahashi H, LeGout J, Kawashima A, Froemming A, Mynderse L, Dora C, Humphreys M, Klug J, Korfiatis P, Erickson B, Takahashi N. Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer. Abdom Radiol (NY). 2024 Oct; 49 (10):3722-3734 Epub 2024 June 19
   View PubMed
5. Riederer SJ, Borisch EA, Du Q, Froemming AT, Hulshizer TC, Kawashima A, McGee KP, Robb F, Rossman PJ, Takahashi N. Application of high-density 2D receiver coil arrays for improved SNR in prostate MRI. Magn Reson Med. 2024 Sep 25 Epub 2024 Sept 25
   View PubMed
6. Riederer SJ, Borisch EA, Froemming AT, Kawashima A, Takahashi N. Comparison of model-based versus deep learning-based image reconstruction for thin-slice T2-weighted spin-echo prostate MRI. Abdom Radiol (NY). 2024 Aug; 49 (8):2921-2931 Epub 2024 Mar 23
   View PubMed
7. Cai JC, Nakai H, Kuanar S, Froemming AT, Bolan CW, Kawashima A, Takahashi H, Mynderse LA, Dora CD, Humphreys MR, Korfiatis P, Rouzrokh P, Bratt AK, Conte GM, Erickson BJ, Takahashi N. Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI. Radiology. 2024 Aug; 312 (2):e232635
   View PubMed
8. Kirby JW, Horst KK, Boyum JH, Thiels CA, Froemming AT, Khandelwal A. The Acute Abdomen: A Case-based Survival Guide to What the Surgeon Wants to Know. Radiographics. 2024 May; 44 (5):e230161
   View PubMed
9. Nakai H, Takahashi H, Adamo DA, LeGout JD, Kawashima A, Thomas JV, Froemming AT, Kuanar S, Lomas DJ, Humphreys MR, Dora C, Takahashi N. Decreased prostate MRI cancer detection rate due to moderate to severe susceptibility artifacts from hip prosthesis. Eur Radiol. 2024 May; 34 (5):3387-3399 Epub 2023 Oct 27
   View PubMed
10. Nagayama H, Nakai H, Takahashi H, Froemming AT, Kawashima A, Bolan CW, Adamo DA, Carter RE, Fazzio RT, Tsuji S, Lomas DJ, Mynderse LA, Humphreys MR, Dora C, Takahashi N. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI Performed for Clinical Suspicion of Prostate Cancer. J Am Coll Radiol. 2024 Mar; 21 (3):398-408 Epub 2023 Oct 10
    View PubMed
11. Nakai H, Nagayama H, Takahashi H, Froemming AT, Kawashima A, Bolan CW, Adamo DA, Carter RE, Fazzio RT, Tsuji S, Lomas DJ, Mynderse LA, Humphreys MR, Dora C, Takahashi N. Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients With Low-Grade Cancer. J Am Coll Radiol. 2024 Mar; 21 (3):387-397 Epub 2023 Oct 12
    View PubMed
12. Turkbey B, Oto A, Allen BC, Akin O, Alexander LF, Ari M, Froemming AT, Fulgham PF, Gettle LM, Maranchie JK, Rosenthal SA, Schieda N, Schuster DM, Venkatesan AM, Lockhart ME, Expert Panel on Urologic Imaging. ACR Appropriateness Criteria(R) Post-Treatment Follow-up of Prostate Cancer: 2022 Update. J Am Coll Radiol 2023 May; 20 (5S):S164-S186
    View PubMed
13. Borisch EA, Froemming AT, Grimm RC, Kawashima A, Trzasko JD, Riederer SJ. Model-based image reconstruction with wavelet sparsity regularization for through-plane resolution restoration in T(2) -weighted spin-echo prostate MRI. Magn Reson Med. 2023 Jan; 89 (1):454-468 Epub 2022 Sept 12
    View PubMed
14. Boss MA, Snyder BS, Kim E, Flamini D, Englander S, Sundaram KM, Gumpeni N, Palmer SL, Choi H, Froemming AT, Persigehl T, Davenport MS, Malyarenko D, Chenevert TL, Rosen MA. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701). J Magn Reson Imaging. 2022 Sep; 56 (3):668-679 Epub 2022 Feb 10
    View PubMed
15. Takeuchi M, Froemming AT, Kawashima A, Thapa P, Carter RE, Cheville JC, Thompson RH, Takahashi N. Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation. Abdom Radiol (NY). 2022 Jun; 47 (6):2168-2177 Epub 2022 Apr 05
    View PubMed
16. Tanaka T, Kawashima A, Rangel LJ, Schulte PJ, Froemming AT, King BF, Mynderse LA, Karnes RJ. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent Prostate Cancer in Patients with Biochemical Recurrence following Radical Prostatectomy. J Urol. 2022 May; 207 (5):1038-1047 Epub 2022 Jan 04
    View PubMed
17. Flug JA, Stellmaker JA, Sharpe RE Jr, Jokerst CE, Tollefson CD, Bowman AW, Nordland M, Hannafin CL, Froemming AT. Kaizen Process Improvement in Radiology: Primer for Creating a Culture of Continuous Quality Improvement. Radiographics. 2022 May-Jun; 42 (3):919-928 Epub 2022 Mar 25
    View PubMed
18. Rhodes NG, Johnson TF, Boyum JH, Khandelwal A, Howell BD, Froemming AT, Behfar A. Radiology of Intra-Aortic Balloon Pump Catheters. Radiol Cardiothorac Imaging. 2022 Apr; 4 (2):e210120 Epub 2022 Apr 14
    View PubMed
19. Takahashi H, Yoshida K, Kawashima A, Lee NJ, Froemming AT, Adamo DA, Khandelwal A, Bolan CW, Heller MT, Hartman RP, Kim B, Philbrick KA, Carter RE, Mynderse LA, Humphreys MR, Cai JC, Takahashi N. Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI. PLoS One. 2022; 17 (5):e0268829 Epub 2022 May 23
    View PubMed
20. Horst KK, Kolbe AB, McDonald JS, Froemming AT, Parvinian A, Klinkner DB, Binkovitz LA. Imaging pediatric acute appendicitis during the coronavirus disease 2019 (COVID-19) pandemic: collateral damage is variable. Pediatr Radiol. 2021 Oct; 51(11):1991-1999. Epub 2021 Aug 17.
    View PubMed
21. Nogel SJ, Ren L, Yu L, Takahashi N, Froemming AT. Feasibility of Dual-Energy Computed Tomography Imaging of Gadolinium-Based Contrast Agents and Its Application in Computed Tomography Cystography: An Exploratory Study to Assess an Alternative Option When Iodinated Contrast Agents Are Contraindicated. J Comput Assist Tomogr. 2021 Aug 16 [Epub ahead of print]
    View PubMed
22. Breen WG, Stish BJ, Harmsen WS, Froemming AT, Mynderse LA, Choo CR, Davis BJ, Pisansky TM. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer. Radiother Oncol. 2021 Aug; 161:9-15 Epub 2021 May 21
    View PubMed
23. Mohammadinejad P, Kwapisz L, Fidler JL, Sheedy SP, Heiken JP, Khandelwal A, Wells ML, Froemming AT, Hansel SL, Lee YS, Inoue A, Halaweish AF, McCollough CH, Bruining DH, Fletcher JG. The utility of a dual-phase, dual-energy CT protocol in patients presenting with overt gastrointestinal bleeding. Acta Radiol Open. 2021 Jul; 10 (7):20584601211030658 Epub 2021 July 27
    View PubMed
24. Allen BC, Oto A, Akin O, Alexander LF, Froemming AT, Fulgham PF, Halpern DJ, Gettle LM, Maranchie JK, Patel BN, Patlas MN, Schieda N, Solanki A, Turkbey IB, Venkatesan AM, Yoo DC, Lockhart ME, Expert Panel on Urological Imaging. ACR Appropriateness Criteria(R) Post-Treatment Surveillance of Bladder Cancer: 2021 Update. J Am Coll Radiol 2021 May; 18 (5S):S126-S138
    View PubMed
25. Doolittle DA, Hernandez MC, Baffour FI, Moynagh MR, Takahashi N, Froemming AT, Glazebrook KN, Kim BD. CT-derived sarcopenia should not preclude surgical stabilization of traumatic rib fractures. Eur Radiol Exp. 2021 Feb 16; 5 (1):9
    View PubMed
26. Takahashi H, Froemming AT, Bruining DH, Karnes RJ, Jimenez RE, Takahashi N. Prostate MRI characteristics in patients with inflammatory bowel disease. Eur J Radiol. 2021 Feb; 135:109503 Epub 2021 Jan 05
    View PubMed
27. Takahashi H, Kawashima A, Inoue A, Kozaka K, Potretzke TA, Froemming AT, Boorjian SA, Humphreys MR, Takahashi N. Hemosiderin deposition in papillary renal cell carcinoma and its potential to mask enhancement on MRI: analysis of 110 cases. Eur Radiol. 2020 Nov; 30 (11):6033-6041 Epub 2020 June 09
    View PubMed
28. Kargar S, Borisch EA, Froemming AT, Grimm RC, Kawashima A, King BF, Stinson EG, Riederer SJ. Modified acquisition strategy for reduced motion artifact in super resolution T 2 FSE multislice MRI: Application to prostate. Magn Reson Med. 2020 Nov; 84 (5):2537-2550 Epub 2020 May 17
    View PubMed
29. Venkatesan AM, Oto A, Allen BC, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Gettle LM, Maranchie JK, Patel BN, Schieda N, Schuster DM, Turkbey IB, Lockhart ME, Expert Panel on Urological Imaging. ACR Appropriateness Criteria(R) Recurrent Lower Urinary Tract Infections in Females. J Am Coll Radiol. 2020 Nov; 17 (11S):S487-S496
    View PubMed
30. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Futterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020 Jul; 296 (1):76-84 Epub 2020 Apr 21
    View PubMed
31. Potretzke TA, Froemming AT, Gupta RT. Post-treatment prostate MRI. Abdom Radiol (NY). 2020 Jul; 45 (7):2184-2197
    View PubMed
32. Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, Marshall AL, Virk A, Carmona EM. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting. Mayo Clin Proc. 2020 Jul; 95 (7):1467-1481 Epub 2020 May 30
    View PubMed
33. Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. 2020 Jun 10; 38 (17):1963-1996 Epub 2020 Jan 15
    View PubMed
34. Tanaka T, Yang M, Froemming AT, Bryce AH, Inai R, Kanazawa S, Kawashima A. Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review. Radiographics. 2020 May-Jun; 40 (3):709-726 Epub 2020 Mar 20
    View PubMed
35. Yoshida K, Takahashi N, Karnes RJ, Froemming AT. Prostatic Remnant After Prostatectomy: MR Findings and Prevalence in Clinical Practice. AJR Am J Roentgenol. 2020 Jan; 214 (1):W37-W43 Epub 2019 Oct 31
    View PubMed
36. Alexander LF, Oto A, Allen BC, Akin O, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Maranchie JK, Mody RN, Patel BN, Schieda N, Schuster DM, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME, Expert Panel on Urological Imaging. ACR Appropriateness Criteria(R) Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia. J Am Coll Radiol. 2019 Nov; 16 (11S):S378-S383
    View PubMed
37. Allen BC, Oto A, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Lloyd S, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Vapiwala N, Venkatesan AM, Wang CL, Yoo DC, Lockhart ME, Expert Panel on Urologic Imaging. ACR Appropriateness Criteria(R) Post-Treatment Surveillance of Bladder Cancer. J Am Coll Radiol. 2019 Nov; 16 (11S):S417-S427
    View PubMed
38. Heller MT, Oto A, Allen BC, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Mackenzie DC, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME, Expert Panel on Urological Imaging. ACR Appropriateness Criteria(R) Penetrating Trauma-Lower Abdomen and Pelvis. J Am Coll Radiol. 2019 Nov; 16 (11S):S392-S398
    View PubMed
39. Butt YM, Smith ML, Tazelaar HD, Vaszar LT, Swanson KL, Cecchini MJ, Boland JM, Bois MC, Boyum JH, Froemming AT, Khoor A, Mira-Avendano I, Patel A, Larsen BT. Pathology of Vaping-Associated Lung Injury. N Engl J Med 2019 Oct 31; 381 (18):1780-1781 Epub 2019 Oct 02
    View PubMed
40. Olson MC, Fletcher JG, Nagpal P, Froemming AT, Khandelwal A. Mesenteric ischemia: what the radiologist needs to know. Cardiovasc Diagn Ther. 2019 Aug; 9 (Suppl 1):S74-S87
    View PubMed
41. Kargar S, Borisch EA, Froemming AT, Grimm RC, Kawashima A, King BF, Stinson EG, Riederer SJ. Use of kZ -space for high through-plane resolution in multislice MRI: Application to prostate. Magn Reson Med. 2019 Jun; 81 (6):3691-3704 Epub 2019 Mar 07
    View PubMed
42. Wang CL, Aryal B, Oto A, Allen BC, Akin O, Alexander LF, Bardo DME, Chong J, Froemming AT, Fulgham PF, Heller MT, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Venkatesan AM, Yoo DC, Lockhart ME, Expert Panel on Urological Imaging . ACR Appropriateness Criteria((R)) Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass. J Am Coll Radiol. 2019 May; 16 (5S):S38-S43
    View PubMed
43. Tanaka T, Froemming AT, Panda A, Edmonson HA, Pooley RA, Carter RE, King BF, Kawashima A. Safety and Image Quality of 1.5-T Endorectal Coil Multiparametric MRI of the Prostate or Prostatectomy Fossa for Patients With Pacemaker or Implantable Cardioverter-Defibrillator. AJR Am J Roentgenol. 2019 Apr; 212 (4):815-822 Epub 2019 Jan 30
    View PubMed
44. Doolittle DA, Froemming AT, Cox CW. High-pitch versus standard mode CT pulmonary angiography: a comparison of indeterminate studies. Emerg Radiol. 2019 Apr; 26 (2):155-159 Epub 2018 Nov 13
    View PubMed
45. Wells ML, Hansel SL, Bruining DH, Fletcher JG, Froemming AT, Barlow JM, Fidler JL. CT for Evaluation of Acute Gastrointestinal Bleeding. Radiographics. 2018 Jul-Aug; 38 (4):1089-1107 Epub 2018 June 08
    View PubMed
46. Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Eur Urol. 2018 Jun; 73 (6):879-887 Epub 2017 Nov 28
    View PubMed
47. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budaus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM, PRECISION Study Group Collaborators, PRECISION Study Group Collaborators. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018 May 10; 378 (19):1767-1777 Epub 2018 Mar 18
    View PubMed
48. Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM, Expert Panel on Urologic Imaging:. ACR Appropriateness Criteria((R)) Post-treatment Follow-up Prostate Cancer. J Am Coll Radiol. 2018 May; 15 (5S):S132-S149
    View PubMed
49. van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME, Expert Panel on Urologic Imaging:. ACR Appropriateness Criteria((R)) Pretreatment Staging of Muscle-Invasive Bladder Cancer. J Am Coll Radiol. 2018 May; 15 (5S):S150-S159
    View PubMed
50. Kargar S, Borisch EA, Froemming AT, Kawashima A, Mynderse LA, Stinson EG, Trzasko JD, Riederer SJ. Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate. Magn Reson Imaging. 2018 May; 48:50-61 Epub 2017 Dec 24
    View PubMed
51. Warndahl BA, Borisch EA, Kawashima A, Riederer SJ, Froemming AT. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement. Magn Reson Imaging. 2018 Apr; 47:67-76 Epub 2017 Dec 05
    View PubMed
52. Froemming A, Potretzke T, Takahashi N, Kim B. Upper tract urothelial cancer. Eur J Radiol. 2018 Jan; 98:50-60 Epub 2017 Nov 08
    View PubMed
53. Wells ML, Froemming AT, Kawashima A, Vrtiska TJ, Kim B, Hartman RP, Holmes DR 3rd, Carter RE, Bartley AC, Leng S, McCollough CH, Fletcher JG. A multi-reader in vitro study using porcine kidneys to determine the impact of integrated circuit detectors and iterative reconstruction on the detection accuracy, size measurement, and radiation dose for small (<4 mm) renal stones. Acta Radiol. 2017 Aug; 58: (8)1012-1019.
    View PubMed
54. Riederer SJ, Borisch EA, Froemming AT, Grimm RC, Kawashima A, Mynderse LA, Trzasko JD. Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array. Magn Reson Imaging. 2017 Jun; 39:15-23 Epub 2017 Jan 27
    View PubMed
55. Morlacco A, Sharma V, Viers BR, Rangel LJ, Carlson RE, Froemming AT, Karnes RJ. The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy. Eur Urol. 2017 May; 71 (5):701-704 Epub 2016 Aug 28
    View PubMed
56. Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC, Expert Panel on Urologic Imaging:. ACR Appropriateness Criteria((R)) Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol. 2017 May; 14 (5S):S245-S257
    View PubMed
57. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with (11)C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging. J Urol. 2017 Jan; 197 (1):129-134 Epub 2016 July 20
    View PubMed
58. Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil. Pract Radiat Oncol. 2017 Jan - Feb; 7 (1):42-49 Epub 2016 June 14
    View PubMed
59. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary mapping of post-prostatectomy prostate cancer relapse with c-11-choline positron emission tomography and multiparametric magnetic resonance imaging Journal Of Urology. 2017 Jan; 197(1):129-34. Epub 1900 Jan 01.
    
60. Rosenkrantz AB, Ginocchio LA, Cornfeld D, Froemming AT, Gupta RT, Turkbey B, Westphalen AC, Babb JS, Margolis DJ. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists. Radiology. 2016 Sep; 280 (3):793-804 Epub 2016 Apr 01
    View PubMed
61. Gunn ML, Marin JR, Mills AM, Chong ST, Froemming AT, Johnson JO, Kumaravel M, Sodickson AD. A report on the Academic Emergency Medicine 2015 consensus conference "Diagnostic imaging in the emergency department: a research agenda to optimize utilization". Emerg Radiol. 2016 Aug; 23 (4):383-96 Epub 2016 May 27
    View PubMed
62. Takahashi N, Takeuchi M, Sasaguri K, Leng S, Froemming A, Kawashima A. CT negative attenuation pixel distribution and texture analysis for detection of fat in small angiomyolipoma on unenhanced CT. Abdom Radiol (NY). 2016 Jun; 41 (6):1142-51
    View PubMed
63. Kolbe AB, Fletcher JG, Froemming AT, Sheedy SP, Koo CW, Pundi K, Bruining DH, Tung J, Harmsen WS, Barlow JM, Fidler JL. Evaluation of Patient Tolerance and Small-Bowel Distention With a New Small-Bowel Distending Agent for Enterography. AJR Am J Roentgenol. 2016 May; 206: (5)994-1002.
    View PubMed
64. Boland JM, Froemming AT, Wampfler JA, Maldonado F, Peikert T, Hyland C, de Andrade M, Aubry MC, Yang P, Yi ES. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules. Hum Pathol. 2016 May; 51:41-50 Epub 2015 Dec 30
    View PubMed
65. Gupta RT, Spilseth B, Froemming AT. How and why a generation of radiologists must be trained to accurately interpret prostate mpMRI. Abdom Radiol (NY). 2016 May; 41 (5):803-4
    View PubMed
66. May EJ, Viers LD, Viers BR, Kawashima A, Kwon ED, Karnes RJ, Froemming AT. Prostate cancer post-treatment follow-up and recurrence evaluation. Abdom Radiol (NY). 2016 May; 41 (5):862-76
    View PubMed
67. Dosanjh G, Froemming AT, Sweetser S. Milky Diarrhea and Ascites. Gastroenterology. 2016 Feb; 150: (2)e3-4.
    View PubMed
68. Sabbatini AK, Merck LH, Froemming AT, Vaughan W, Brown MD, Hess EP, Applegate KE, Comfere NI. Optimizing Patient-centered Communication and Multidisciplinary Care Coordination in Emergency Diagnostic Imaging: A Research Agenda. Acad Emerg Med. 2015 Dec; 22 (12):1427-34 Epub 2015 Nov 17
    View PubMed
69. Kitajima K, Hartman RP, Froemming AT, Hagen CE, Takahashi N, Kawashima A. Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI. AJR Am J Roentgenol. 2015 Oct; 205: (4)807-16.
    View PubMed
70. Capek S, Howe BM, Froemming AT, Amrami KK, Spinner RJ. Perineural spread in pelvic malignancies can be an alternate explanation for pelvic bony metastases rather than hematogenous spread. A report of two cases. Skeletal Radiol. 2015 Sep; 44 (9):1365-70 Epub 2015 Apr 12
    View PubMed
71. Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med. 2014 Feb; 55 (2):223-32 Epub 2014 Jan 16
    View PubMed
72. Froemming AT, Kawashima A, Takahashi N, Hartman RP, Nathan MA, Carter RE, Yu L, Leng S, Kagoshima H, McCollough CH, Fletcher JG. Individualized kV selection and tube current reduction in excretory phase computed tomography urography: potential for radiation dose reduction and the contribution of iterative reconstruction to image quality. J Comput Assist Tomogr. 2013 Jul-Aug; 37(4):551-9.
    View PubMed
73. Froemming AT, Boland J, Cheville J, Takahashi N, Kawashima A. Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol. 2013 Feb; 200 (2):W178-86
    View PubMed
74. Christensen KN, Harris SR, Froemming AT, Brinjikji W, Araoz P, Asirvatham SJ, Lachman N. Anatomic assessment of the bifurcation of the left main coronary artery using multidetector computed tomography. Surg Radiol Anat. 2010 Dec; 32 (10):903-9 Epub 2010 Feb 27
    View PubMed
75. Brinjikji W, Harris SR, Froemming AT, Christensen KN, Lachman N, Araoz PA. Descriptive anatomy of the dominant septal perforators using Dual Source Coronary CT Angiography. Clin Anat. 2010 Jan; 23 (1):70-8
    View PubMed
76. Froemming A, Atwell T, Farrell M, Callstrom M, Leibovich B, Charboneau W. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol. 2010 Jan; 21 (1):148-51
    View PubMed